Diabetologia

Article	Citations
TBC1D30 regulates proinsulin and insulin secretion and is the target of a genomic association signal for proinsulin	528
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question. Reply to Kanter M [letter]	243
Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca2+ dynamics in prediabetic beta cells	210
The SWI/SNF chromatin remodelling complex regulates pancreatic endocrine cell expansion and differentiation in mice in vivo	205
Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation	188
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy	162
MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway	131
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]	131
Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study	117
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory	114
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes	111
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study	110
Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq	100
Up Front	98
Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT	93
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification	90
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes	78
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities	76
Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes	76
60th EASD Annual Meeting of the European Association for the Study of Diabetes	73
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes	72
Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study	71
Scientists and scientific journals should adhere to ethical standards for the use and reporting of data from Indigenous people	70
Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study	69
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)	67

58th EASD Annual Meeting of the European Association for the Study of Diabetes	67
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care	65
Ageing well with diabetes: the role of technology	65
Markers of metabolic health and gut microbiome diversity: findings from two population-based cohort studies	62
Loneliness increases the risk of type 2 diabetes: a 20 year follow-up – results from the HUNT study	60
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials	60
Pinpointing precision medicine for diabetes mellitus	59
Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity	59
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications	58
Systematic genetic testing for recessively inherited monogenic diabetes: a cross-sectional study in paediatric diabetes clinics	57
Does nocturnal hypoglycaemia really improve quality of life?	57
Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults	55
Mortality risk for kidney transplant candidates with diabetes: a population cohort study	55
Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy	52
Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity	52
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes	52
Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study	51
Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women	51
A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk	50
Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals	50
Frequency and clinical characteristics of children and young people with type 2 diabetes at diagnosis from five world regions between 2012 and 2021: data from the SWEET Registry	49
Retinal arteriolar tortuosity and fractal dimension are associated with long-term cardiovascular outcomes in people with type 2 diabetes	49
Up Front	49
Immunoregulated insulitis and slow-progressing type 1 diabetes after duodenopancreatectomy	48
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open	48
Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial	47
Daniel Porte Jr, 13 August 1931–13 May 2023	47
eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes	47
Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis	46
GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap	46
Effects of progressive resistance training in individuals with type 2 diabetic polyneuropathy: a randomised assessor-blinded controlled trial	45
The role of automated insulin delivery technology in diabetes	44
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial	44
The COVID-19 pandemic may be receding but the diabetes pandemic rages on	43
Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data	43
Presence of immunogenic alternatively spliced insulin gene product in human pancreatic delta cells	42
ICAM-1 on the luminal surface of endothelial cells is induced to a greater extent in mouse retina than in other tissues in diabetes	42
Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort	41
Glucose-stimulated insulin secretion depends on FFA1 and Gq in neonatal mouse islets	41
Intestinal neutrophil extracellular traps promote gut barrier damage exacerbating endotoxaemia, systemic inflammation and progression of diabetic retinopathy in type 2 diabetes	41
(Pre)diabetes and a higher level of glycaemic measures are continuously associated with corneal neurodegeneration assessed by corneal confocal microscopy: the Maastricht Study	41
Distinct subcellular localisation of intramyocellular lipids and reduced PKCε/PKCθ activity preserve muscle insulin sensitivity in exercise-trained mice	41
Identification and interpretation of risk factors for Charcot foot	39
Activation of the hypoxia-inducible factor pathway by roxadustat improves glucose metabolism in human primary myotubes from men	39
Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative Islet Transplant Registry	38
Reduced beta cell number rather than size is a major contributor to beta cell loss in type 2 diabetes	38
Genetics of diabetes-associated microvascular complications	38
Diabetes concomitant to aortic stenosis is associated with increased expression of NF-κB and more pronounced valve calcification	38
The use of automated insulin delivery around physical activity and exercise in type 1 diabetes: a position statement of the European Association for the Study of Diabetes (EASD) and the International	38
Bo Hellman, 19 June 1930–4 December 2023	38

High proinsulin:C-peptide ratio identifies individuals with stage 2 type 1 diabetes at high risk for progression to clinical diagnosis and responses to teplizumab treatment	37
Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover	37
Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes	37
Exercise facilities and the prevalence of obesity and type 2 diabetes in the city of Madrid	36
Twenty-four hour assessments of substrate oxidation reveal differences in metabolic flexibility in type 2 diabetes that are improved with aerobic training	36
Fatty acid-binding protein 4: a key regulator of ketoacidosis in new-onset type 1 diabetes	36
tRNA-derived fragments in T lymphocyte–beta cell crosstalk and in type 1 diabetes pathogenesis in NOD mice	36
Correction: Applying technologies to simplify strategies for exercise in type 1 diabetes	35
Increasing evidence of the benefits of a transition coordinator in type 1 diabetes	35
Reversibility of brain glucose kinetics in type 2 diabetes mellitus	35
Evidence on the effectiveness and equity of population-based policies to reduce the burden of type 2 diabetes: a narrative review	35
Investigating the causal relationships between excess adiposity and cardiometabolic health in men and women	34
Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China	34
MTNR1B genotype and effects of carbohydrate quantity and dietary glycaemic index on glycaemic response to an oral glucose load: the OmniCarb trial	34
Diabetes and climate change: current evidence and implications for people with diabetes, clinicians and policy stakeholders	34
The metabolic potential of inflammatory and insulinaemic dietary patterns and risk of type 2 diabetes	33
Technology in the management of diabetes in hospitalised adults	33
Incretins: turning the venom into the antidote	33
Up Front	32
Up Front	32
Genetic relations between type 1 diabetes, coronary artery disease and leukocyte counts	32
Women in diabetes research: we can do better. Reply to Bonnefond A [letter]	32
Umbilical cord blood DNA methylation in children who later develop type 1 diabetes	31
Skeletal muscle and intermuscular adipose tissue gene expression profiling identifies new biomarkers with prognostic significance for insulin resistance progression and intervention response	31
Characteristics of adults with type 1 diabetes and treatment-resistant problematic hypoglycaemia: a baseline analysis from the HARPdoc RCT	31
The contribution of functional HNF1A variants and polygenic susceptibility to risk of type 2 diabetes in ancestrally diverse populations	31
Adiponectin deficiency induces hepatic steatosis during pregnancy and gestational diabetes in mice	31
Discovery and validation of plasma, saliva and multi-fluid plasma–saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults	30
The metabolome as a diagnostic for maximal aerobic capacity during exercise in type 1 diabetes	30
Editorial Expression of Concern: Effects of calcium–vitamin D co-supplementation on glycaemic control, inflammation and oxidative stress in gestational diabetes: a randomised placebo-controlled trial	30
Transgender healthcare: metabolic outcomes and cardiovascular risk	30
Genetic variation in the RETN promoter, accompanied by latent sarcopenic obesity, led to insulin resistance in a Japanese cohort: the Toon Genome Study	30
IAPP-induced beta cell stress recapitulates the islet transcriptome in type 2 diabetes	30
An unclear role for the GLP-1 metabolite GLP-1(9–36) in human islet physiology	30
Maturation of beta cells: lessons from in vivo and in vitro models	29
Safety and effectiveness of SGLT2 inhibitors in a UK population with type 2 diabetes and aged over 70 years: an instrumental variable approach	29
Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy	29
Elevated cerebrospinal fluid glucose levels and diabetes mellitus are associated with activation of the neurotoxic polyol pathway	29
Differential CpG methylation at Nnat in the early establishment of beta cell heterogeneity	29
Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes	29
Accuracy of continuous glucose monitoring in the hospital setting: an observational study	29
Hyperbaric oxygen rapidly improves tissue-specific insulin sensitivity and mitochondrial capacity in humans with type 2 diabetes: a randomised placebo-controlled crossover trial	29
Associations between parental type 2 diabetes risk and offspring birthweight and placental weight: a survival analysis using the Walker cohort	28
Implicating type 2 diabetes effector genes in relevant metabolic cellular models using promoter-focused Capture-C	28
Precision prognostics for the development of complications in diabetes	27
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis	27
Pancreatic exocrine damage induces beta cell stress in zebrafish larvae	27
Coeliac disease and type 2 diabetes risk: a nationwide matched cohort and Mendelian randomisation study	27
Autoimmune comorbidity in type 1 diabetes and its association with metabolic control and mortality risk in young people: a population-based study	27
Characterisation of Ppy-lineage cells clarifies the functional heterogeneity of pancreatic beta cells in mice	27
Association of maternal vitamin B12 and folate levels in early pregnancy with gestational diabetes: a prospective UK cohort study (PRiDE study)	27
Investigating causality in the association between DNA methylation and type 2 diabetes using bidirectional two-sample Mendelian randomisation	27
The utility of a type 2 diabetes polygenic score in addition to clinical variables for prediction of type 2 diabetes incidence in birth, youth and adult cohorts in an Indigenous study population	27
A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY	27
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia? Reply to Sánchez‑Hernández and Wägner [letter]	26
The extent and magnitude of islet T cell infiltration as powerful tools to define the progression to type 1 diabetes	26
Birthweight and risk of chronic kidney disease after a type 2 diabetes diagnosis in the DD2 cohort	26
The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app	25
Progression of type 1 diabetes is associated with high levels of soluble PD-1 in islet autoantibody-positive children	25
High levels of blood circulating immune checkpoint molecules in children with new-onset type 1 diabetes are associated with the risk of developing an additional autoimmune disease	25
Characteristics of autoantibody-positive individuals without high-risk HLA-DR4-DQ8 or HLA-DR3-DQ2 haplotypes	25
Correction to: Associations of combined healthy lifestyles with cancer morbidity and mortality among individuals with diabetes: results from five cohort studies in the USA, the UK and China	25
The impact of population-level HbA1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis	25
Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementat	25
Metabolomic and genetic architecture of gestational diabetes subtypes	24
Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing	24
Identification of type 1 diabetes risk phenotypes using an outcome-guided clustering analysis	24
Long-term trajectories of sleep duration are associated with incident diabetes in middle-to-older-aged Black and White Americans	24
Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study	24
Effects of atmospheric pressure change during flight on insulin pump delivery and glycaemic control of pilots with insulin-treated diabetes: an in vitro simulation and a retrospective observational re	24
Exploring the shared genetic landscape of diabetes and cardiovascular disease: findings and future implications	24
RFX3 is essential for the generation of functional human pancreatic islets from stem cells	24
Apolipoprotein L genes are novel mediators of inflammation in beta cells	24
Relationship between sRAGE and obesity in individuals with type 1 diabetes during a median follow-up of 6.3 years	23
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification. Reply by Lean et al to Ludvigsson J [letter]	23
Childhood adiposity and novel subtypes of adult-onset diabetes: a Mendelian randomisation and genome-wide genetic correlation study	23
Correction to: Advances and challenges in measuring hepatic glucose uptake with FDG PET: implications for diabetes research	23
Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial	23
Retraction Note: Annexin A1 attenuates microvascular complications through restoration of Akt signalling in a murine model of type 1 diabetes	23
GLP-1 receptor nitration contributes to loss of brain pericyte function in a mouse model of diabetes	23

Achievements, prospects and challenges in precision care for monogenic insulin-deficient and insulin-resistant diabetes	23
The genetics of low and high birthweight and their relationship with cardiometabolic disease	23
Precision nutrition in diabetes: when population-based dietary advice gets personal	23
Technology advances in diabetes pregnancy: right technology, right person, right time	22
Epidemiology of hypoglycaemic episodes leading to hospitalisations in Denmark in 1998–2018	22
Women in diabetes research: we can do better	22
Leveraging artificial intelligence and machine learning to accelerate discovery of disease-modifying therapies in type 1 diabetes	22
Correction to: Youth-onset type 2 diabetes: translating epidemiology into clinical trials	22
Referees 2024	22
Depleting hypothalamic somatostatinergic neurons recapitulates diabetic phenotypes in mouse brain, bone marrow, adipose and retina	22
ADHD should be considered in adolescents with type 1 diabetes and poor metabolic control	22
Comments on the notion of false positivity in measurements of autoantibodies. Reply to Grill V, Sørgjerd E, Hals I, Carlsson S [letter]	21
Mediators of the association between educational attainment and type 2 diabetes mellitus: a two-step multivariable Mendelian randomisation study	21
Diabetes and natural and man-made disasters: prevention, preparation, response and recovery	21
Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage	21
Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on risk of diabetic eye complications	21
Novel secreted regulators of glucose and lipid metabolism in the development of metabolic diseases	21
Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4	21
Paternal eNOS deficiency in mice affects glucose homeostasis and liver glycogen in male offspring without inheritance of eNOS deficiency itself	20
Sex differences in body composition in people with prediabetes and type 2 diabetes as compared with people with normal glucose metabolism: the Maastricht Study	20
TMEM55A-mediated PI5P signalling regulates alpha cell actin depolymerisation and glucagon secretion	20
Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials	20
Heterogeneity of glycaemic phenotypes in type 1 diabetes	20
Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrPC, in type 1 diabetes	20
Association between timing and consistency of physical activity and type 2 diabetes: a cohort study on participants of the UK Biobank	20
Up Front	19
Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation	19
Detection of enterovirus RNA in pancreas and lymphoid tissues of organ donors with type 1 diabetes	19
Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants	19
Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial	19
The insulin hypersecretion hypothesis: cause or effect? Reply to Polychronakos C [letter]	19
Acculturation and glycaemic control in Arab immigrants with type 2 diabetes in Australia	19
SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits	19
Up Front	19
Lipids, hyperreflective crystalline deposits and diabetic retinopathy: potential systemic and retinal-specific effect of lipid-lowering therapies	18
Acute hyperglycaemia does not have a consistent adverse effect on exercise performance in recreationally active young people with type 1 diabetes: a randomised crossover in-clinic study	18
Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial	18
Correction: Discovery and validation of plasma, saliva and multi-fluid plasma–saliva metabolomic scores predicting insulin resistance and diabetes progression or regression among Puerto Rican adults	18
A polygenic risk score derived from common variants of monogenic diabetes genes is associated with young-onset type 2 diabetes and cardiovascular–kidney complications	18
Risk factors and incidence over time for lower extremity amputations in people with type 1 diabetes: an observational cohort study of 46,088 patients from the Swedish National Diabetes Registry	18
Effectiveness and safety of empagliflozin: final results from the EMPRISE study	17
Metabolic traits affecting the relationship between liver fat and intrapancreatic fat: a mediation analysis	17
Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control	17
ADGRL1 is a glucose receptor involved in mediating energy and glucose homeostasis	17
Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review	17
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers	17
Temporal trends in the prevalence and incidence of depression and the interplay of comorbidities in patients with young- and usual-onset type 2 diabetes from the USA and the UK	17
Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial	17
Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1+/NKX6.1+ progenitors	17
Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice	17
Up Front	17
Spatial proteomics of human diabetic kidney disease, from health to class III	17
Sarah A. Hills RGN MSc, 28 September 1960–1 May 2023	16
A WFS1 variant disrupting acceptor splice site uncovers the impact of alternative splicing on beta cell apoptosis in a patient with Wolfram syndrome	16
Opposing effects on regulated insulin secretion of acute vs chronic stimulation of AMP-activated protein kinase	16
Up front	16
Up Front	16
On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes: Reply to Johnson JD [letter]	16
Should children with type 1 diabetes really receive statin treatment using the same criteria as for children with familial hypercholesterolaemia?	16
Gut microbiota mediate melatonin signalling in association with type 2 diabetes	16
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question	16
Autoimmune diseases and the risk and prognosis of latent autoimmune diabetes in adults	16
Ertugliflozin, renoprotection and potential confounding by muscle wasting	16
Sex differences in type 2 diabetes	16
The 26RFa (QRFP)/GPR103 neuropeptidergic system in mice relays insulin signalling into the brain to regulate glucose homeostasis	15
Morning exercise as fasted-state activity. Reply to Chacko E [letter]	15
Association of maternal diabetes during pregnancy with high refractive error in offspring: a nationwide population-based cohort study	15
Lifetime history of gestational diabetes and cognitive function in parous women in midlife	15
Phenotypic and genetic classification of diabetes	15
Pathophysiology of type 2 diabetes in sub-Saharan Africans	15
An unwelcome inheritance: childhood obesity after diabetes in pregnancy	15
Genetic determinants of type 1 diabetes in individuals with weak evidence of islet autoimmunity at disease onset	15
Glycaemic patterns during breastfeeding with postpartum use of closed-loop insulin delivery in women with type 1 diabetes	15
Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events	15
Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease	15
Leveraging human genetic data to investigate the cardiometabolic effects of glucose-dependent insulinotropic polypeptide signalling	15
Loss of RREB1 in pancreatic beta cells reduces cellular insulin content and affects endocrine cell gene expression	15
Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?	15
Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetes	15
Beta cell-specific PAK1 enrichment ameliorates diet-induced glucose intolerance in mice by promoting insulin biogenesis and minimising beta cell apoptosis	15
Retinal microvascular associations with cardiometabolic risk factors differ by diabetes status: results from the UK Biobank	15
What else can we do to prevent diabetic retinopathy?	15
High-intensity interval training for 12 weeks improves cardiovascular autonomic function but not somatosensory nerve function and structure in overweight men with type 2 diabetes	15
Associations of plasma glycerophospholipid profile with modifiable lifestyles and incident diabetes in middle-aged and older Chinese	15
AT2R deficiency in mice accelerates podocyte dysfunction in diabetic progeny in a sex-dependent manner	14
The population-specific Thr44Met OCT3 coding variant affects metformin pharmacokinetics with subsequent effects on insulin sensitivity in C57Bl/6J mice	14
Impaired postprandial skeletal muscle vascular responses to a mixed meal challenge in normoglycaemic people with a parent with type 2 diabetes	14
Up Front	14
Correction to: Consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes	14
Effect of fenofibrate on residual beta cell function in adults and adolescents with newly diagnosed type 1 diabetes: a randomised clinical trial	14
The DPP-4 inhibitor sitagliptin improves glycaemic control and early-stage diabetic nephropathy in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed-loop system: a randomi	14
Correction: Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with recent-onset type 2 d	14
Global experiences and personal narratives on diabetes technology and access	14
How does exposure to overnutrition in utero lead to childhood adiposity? Testing the insulin hypersecretion hypothesis in the EPOCH cohort	14
Up Front	14